Alrizomadlin

未知生产厂商

Alrizomadlin is a novel MDM2 inhibitor that blocks the interaction of MDM2 and p53. It is being investigated in cancers.

医学正文保留数据源原文，避免将未经专业审核的机器翻译呈现为临床事实。

概览

Alrizomadlin is a novel MDM2 inhibitor that blocks the interaction of MDM2 and p53. It is being investigated in cancers.

技术标识符

每项发明一条，涵盖美国、欧洲、PCT 与中国的同族专利。